Associated Papers
ALK Inhibition Prolongs Survival in a Mouse Model of ALK-Positive Anaplastic Thyroid Cancer.
Machlah YM et al.
Thyroid : Official Journal of the American Thyroid Association, 2025
Mutational profiling using liquid biopsy to guide targeted therapy in patients with metastatic cancer.
Mazouji O et al.
Scientific Reports, 2025
Novel ALK gene mutation in inflammatory myofibroblastic tumor of the thyroid: a case report.
Guangxu Y et al.
Frontiers in Oncology, 2025
The genomic landscape of papillary thyroid carcinoma on next-generation sequencing in patients undergoing total thyroidectomy.
Poongkodi K et al.
World Journal of Surgery, 2024
Pathway-based, reaction-specific annotation of disease variants for elucidation of molecular phenotypes.
Orlic-Milacic M et al.
Database : the Journal of Biological Databases and Curation, 2024
Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.
Katic L et al.
Biomolecules, 2023
First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews.
Wu R et al.
Anti-cancer Drugs, 2023
Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era.
Capdevila J et al.
Cancer Treatment Reviews, 2022
Anaplastic lymphoma kinase-special immunity and immunotherapy.
Guo Y et al.
Frontiers in Immunology, 2022
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Hescheler DA et al.
Frontiers in Endocrinology, 2021
Oncogenic ALK F1174L drives tumorigenesis in cutaneous squamous cell carcinoma.
Gualandi M et al.
Life Science Alliance, 2020
Development and Analytical Validation of an Expanded Mutation Detection Panel for Next-Generation Sequencing of Thyroid Nodule Aspirates.
Ablordeppey KK et al.
The Journal of Molecular Diagnostics : Jmd, 2020
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.
Tirrò E et al.
Genes, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling.
Khan SA et al.
Head & Neck, 2019
Targeting anaplastic lymphoma kinase in neuroblastoma.
Umapathy G et al.
Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica, 2019
Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent.
Guan J et al.
Oncotarget, 2017
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
Smith N et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
ALK-rearrangements and testing methods in non-small cell lung cancer: a review.
Shackelford RE et al.
Genes & Cancer, 2014
Recent progress of genome study for anaplastic thyroid cancer.
Lee J et al.
Genomics & Informatics, 2013
Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.
Coco S et al.
Journal of Human Genetics, 2012
Diagnostic and prognostic markers in differentiated thyroid cancer.
Gómez Sáez JM
Current Genomics, 2011
Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.
Murugan AK et al.
Cancer Research, 2011